Total Payments
$196,788
2024 Payments
$45,756
Companies
28
Transactions
564
Medicare Patients
581
Medicare Billing
$58,386
Payment Breakdown by Category
Other$131,960 (67.1%)
Consulting$32,113 (16.3%)
Travel$19,226 (9.8%)
Food & Beverage$13,267 (6.7%)
Education$206.64 (0.1%)
Research$16.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $131,960 | 45 | 67.1% |
| Consulting Fee | $32,113 | 14 | 16.3% |
| Travel and Lodging | $19,226 | 64 | 9.8% |
| Food and Beverage | $13,267 | 428 | 6.7% |
| Education | $206.64 | 12 | 0.1% |
| Unspecified | $16.02 | 1 | 0.0% |
Payments by Type
General
$196,772
563 transactions
Research
$16.02
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $94,435 | 197 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $53,919 | 42 | $0 (2023) |
| Lilly USA, LLC | $23,294 | 42 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $7,996 | 11 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $7,584 | 53 | $0 (2024) |
| PFIZER INC. | $3,379 | 25 | $0 (2024) |
| Celgene Corporation | $2,708 | 45 | $0 (2024) |
| Gilead Sciences, Inc. | $767.69 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $725.58 | 35 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $273.72 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,756 | 162 | ABBVIE INC. ($22,017) |
| 2023 | $58,243 | 169 | AbbVie Inc. ($35,638) |
| 2022 | $89,463 | 208 | E.R. Squibb & Sons, L.L.C. ($42,538) |
| 2021 | $3,041 | 18 | PFIZER INC. ($2,741) |
| 2019 | $18.25 | 1 | Alexion Pharmaceuticals, Inc. ($18.25) |
| 2018 | $39.19 | 3 | KARL STORZ Endoscopy-America ($23.17) |
| 2017 | $226.19 | 3 | AbbVie, Inc. ($125.00) |
All Payment Transactions
564 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $32.31 | General |
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $119.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.91 | General |
| 11/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $625.00 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Immunology | ||||||
| 11/21/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $114.75 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.17 | General |
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 334 | 353 | $180,086 | $33,027 |
| 2022 | 9 | 235 | 276 | $118,030 | $23,976 |
| 2021 | 1 | 12 | 14 | $3,234 | $1,382 |
Total Patients
581
Total Services
643
Medicare Billing
$58,386
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 60 | 60 | $65,940 | $11,876 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 30 | $9,580 | $4,159 | 43.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 57 | 58 | $40,716 | $3,897 | 9.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 35 | $8,337 | $3,382 | 40.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $30,132 | $3,198 | 10.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $5,256 | $1,646 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,641 | $1,587 | 34.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,066 | $1,543 | 30.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 13 | $6,058 | $1,219 | 20.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 58 | 58 | $3,190 | $262.49 | 8.2% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 24 | 26 | $1,170 | $257.31 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 77 | $17,787 | $7,194 | 40.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 41 | 42 | $40,824 | $5,336 | 13.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 18 | 18 | $19,782 | $3,286 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $8,568 | $2,820 | 32.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $20,358 | $2,048 | 10.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $5,694 | $2,045 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $1,872 | $884.85 | 47.3% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2022 | 19 | 21 | $945.00 | $193.69 | 20.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 40 | 40 | $2,200 | $167.52 | 7.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 14 | $3,234 | $1,382 | 42.7% |
About Dr. Joshua Steinberg, MD
Dr. Joshua Steinberg, MD is a Gastroenterology healthcare provider based in Northglenn, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1154749042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Steinberg, MD has received a total of $196,788 in payments from pharmaceutical and medical device companies, with $45,756 received in 2024. These payments were reported across 564 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($131,960).
As a Medicare-enrolled provider, Steinberg has provided services to 581 Medicare beneficiaries, totaling 643 services with total Medicare billing of $58,386. Data is available for 3 years (2021–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Northglenn, CO
- Active Since 03/28/2014
- Last Updated 03/25/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154749042
Products in Payments
- SKYRIZI (Biological) $50,668
- RINVOQ (Biological) $40,135
- ZEPOSIA (Drug) $39,434
- OMVOH (Drug) $13,586
- STELARA (Biological) $8,366
- ENTYVIO (Biological) $7,507
- XELJANZ (Drug) $418.33
- XIFAXAN (Drug) $346.26
- DUPIXENT (Biological) $310.52
- REMICADE (Biological) $288.55
- IBSRELA (Drug) $253.72
- VOQUEZNA (Drug) $228.41
- LINZESS (Drug) $215.40
- HUMIRA (Biological) $208.96
- CREON (Drug) $163.77
- SUCRAID (Drug) $126.48
- Humira (Biological) $125.00
- OCALIVA (Drug) $113.08
- VELSIPITY (Drug) $104.95
- MAVYRET (Drug) $102.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.